EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Potential of Limonium brasiliense Extracts in Helicobacter pylori-Associated Gastric Pathologies

Augusto Santos Borges, Ana Carolina Guidi, Mariana Nascimento de Paula, Eloisa Lorenzi da Silva, Gabriel Jorge Fagundes, Marco Aurélio Valadão Fagundes, Rodrigo Rezende Kitagawa, Rita de Cássia Ribeiro Gonçalves, Daniela Cristina de Medeiros Araújo, João Carlos Palazzo de Mello iD

Planta Medica · 30.07.2026

DOI: 10.1055/a-2897-9285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 30.07.2026. Verfasst von Augusto Santos Borges und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Laboratory of Pharmaceutical Biology, Palafito, Universidade Estadual de Maringá, Brazil. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori infection is related to several gastric pathologies, including gastritis, peptic ulcer, and gastric cancer. Substances capable of eradicating H. pylori have been subject to the attention of researchers. This study evaluated a fully characterized ethyl acetate fraction, obtained from the rhizomes of Limonium brasiliense, and its microparticulate pharmaceutical form against H. pylori, as well as their potential immunomodulatory and antitumor activities associated with H. pylori infection. Ultra-high-performance liquid chromatography analysis of ethyl acetate fraction indicated the presence of samaragenins A and B along with gallic acid, epigallocatechin, and epigallocatechin-3-O-gallate. Antioxidant activity showed half-maximum inhibitory concentration values of 5.7 (95% confidence interval: 5.21 – 6.83), 31.9 (95% confidence interval: 19.57 – 51.99), and 33.1 (95% confidence interval: 24.4 – 44.73) µg/mL for HOCl, O2 •−, and NO, respectively. Ethyl acetate fraction exerted minimal inhibitory concentration values of 1,024 and 128 µg/mL against the H. pylori (ATCC 43 504, clinical isolate H. pylori strain). In vivo treatments in mice with ethyl acetate fraction and microparticulate ethyl acetate fraction (100 mg/kg, in single daily doses for 20 consecutive days) improved gastric pathology in infected animals, reducing urease positivity (14.3% vs. 54.5% in untreated controls), inflammation (tumor necrosis factor alpha, interleukin 1β, and interleukin 6 reduced, p < 0.05), and morphological damage compared with the untreated control group. H. pylori urease was inhibited with half-maximum inhibitory concentration of 521.6 µg/mL (95% confidence interval: 419.2 – 649.0). In addition, ethyl acetate fraction showed antiproliferative activity against gastric adenocarcinoma cells (half cytotoxic concentration of 21.7, 95% confidence interval: 18.1 – 26.04). In Escherichia coli lipopolysaccharide-stimulated macrophages, ethyl acetate fraction reduced the tumor necrosis factor alpha and interleukin 6 production by 16% and 35%, respectively. These results indicate the potential of L. brasiliense as a source of compounds capable of attenuating gastric diseases related to H. pylori infection.

Autor:innen und Institutionen

  • Department of Pharmacy, Laboratory of Pharmaceutical Biology, Palafito, Universidade Estadual de Maringá, Brazil.
  • Department of Medicine, Universidade Estadual de Maringá, Maringá, Brazil.
  • Graduate Program in Pharmaceutical Sciences, Universidade Federal do Espírito Santo, Vitoria, Brazil.

ORCID-Profile: João Carlos Palazzo de Mello

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Borges, A. S., Guidi, A. C., Paula, M. N., Silva, E. L. D., Fagundes, G. J., Fagundes, M. A. V., Kitagawa, R. R., Gonçalves, R. C. R., Araújo, D. C. M., & Mello, J. C. P. (2026). Therapeutic Potential of Limonium brasiliense Extracts in Helicobacter pylori-Associated Gastric Pathologies. Planta Medica. https://doi.org/10.1055/a-2897-9285

Vancouver

Borges AS, Guidi AC, Paula MN, Silva ELD, Fagundes GJ, Fagundes MAV, et al. Therapeutic Potential of Limonium brasiliense Extracts in Helicobacter pylori-Associated Gastric Pathologies. Planta Medica. 2026. doi:10.1055/a-2897-9285

BibTeX
@article{Borges2026,
  author = {Borges, Augusto Santos and Guidi, Ana Carolina and Paula, Mariana Nascimento de and Silva, Eloisa Lorenzi da and Fagundes, Gabriel Jorge and Fagundes, Marco Aurélio Valadão and Kitagawa, Rodrigo Rezende and Gonçalves, Rita de Cássia Ribeiro and Araújo, Daniela Cristina de Medeiros and Mello, João Carlos Palazzo de},
  title = {Therapeutic Potential of Limonium brasiliense Extracts in Helicobacter pylori-Associated Gastric Pathologies},
  journal = {Planta Medica},
  year = {2026},
  doi = {10.1055/a-2897-9285}
}
Kostenlos starten →